| Ribosome biogenesis in eukaryotes |
1.73 |
3.96e-1 |
52/108 (48.15%) |
NVL;LSG1;GTPBP4;...
|
| Chemokine signaling pathway |
1.69 |
2.85e-1 |
163/192 (84.9%) |
CXCL9;PXN;CCL2;...
|
| Mineral absorption |
1.69 |
1.99e-1 |
48/60 (80%) |
MT1F;FTH1;MT1X;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.68 |
1.64e-1 |
84/100 (84%) |
ACKR3;CXCL9;CCL2;...
|
| Homologous recombination |
1.66 |
1.45e-1 |
35/41 (85.37%) |
RAD51C;BRCA1;RPA3;...
|
| VEGF signaling pathway |
1.63 |
1.67e-1 |
50/59 (84.75%) |
PXN;CDC42;BAD;...
|
| Tryptophan metabolism |
1.58 |
2.19e-1 |
35/42 (83.33%) |
KYNU;KMO;MAOA;...
|
| African trypanosomiasis |
1.58 |
1.93e-1 |
32/37 (86.49%) |
HBB;GNAQ;IL1B;...
|
| Protein export |
1.57 |
1.72e-1 |
17/23 (73.91%) |
SEC61G;SRP72;SPCS1;...
|
| Small cell lung cancer |
1.57 |
1.62e-1 |
90/92 (97.83%) |
COL4A5;ITGA6;BIRC3;...
|
| Bacterial invasion of epithelial cells |
1.53 |
2.04e-1 |
59/77 (76.62%) |
PXN;CDC42;CRKL;...
|
| Proteasome |
1.51 |
2.20e-1 |
44/46 (95.65%) |
PSMD6;PSMB9;PSMB1;...
|
| Hematopoietic cell lineage |
1.50 |
2.20e-1 |
90/99 (90.91%) |
IL7R;ITGA6;CD2;...
|
| Folate biosynthesis |
1.49 |
2.27e-1 |
23/26 (88.46%) |
MOCOS;AKR1C3;PAH;...
|
| RNA degradation |
1.48 |
2.29e-1 |
53/79 (67.09%) |
LSM5;PFKP;EXOSC4;...
|
| Mannose type O-glycan biosynthesis |
1.48 |
2.18e-1 |
14/23 (60.87%) |
FUT9;B4GALT3;RXYLT1;...
|
| Fanconi anemia pathway |
1.45 |
2.43e-1 |
36/54 (66.67%) |
FANCI;RMI1;RAD51C;...
|
| Maturity onset diabetes of the young |
1.45 |
2.29e-1 |
21/26 (80.77%) |
HHEX;PAX6;NKX2-2;...
|
| Oocyte meiosis |
1.44 |
2.30e-1 |
90/129 (69.77%) |
PRKACB;CCNB2;CDC20;...
|
| Focal adhesion |
1.42 |
2.76e-1 |
180/201 (89.55%) |
PXN;COL4A5;ITGA6;...
|
| Human immunodeficiency virus 1 infection |
1.36 |
4.06e-1 |
189/212 (89.15%) |
PXN;APOBEC3B;BAD;...
|
| Toxoplasmosis |
1.32 |
4.17e-1 |
103/112 (91.96%) |
ITGA6;BAD;ALOX5;...
|
| Primary immunodeficiency |
1.31 |
4.11e-1 |
33/38 (86.84%) |
IL7R;CD3D;TAP1;...
|
| Pentose phosphate pathway |
1.31 |
4.06e-1 |
25/30 (83.33%) |
PFKP;PRPS1;DERA;...
|
| Protein digestion and absorption |
1.31 |
4.06e-1 |
78/103 (75.73%) |
SLC3A1;COL4A5;COL15A1;...
|
| DNA replication |
1.29 |
4.18e-1 |
34/36 (94.44%) |
RPA3;FEN1;POLD3;...
|
| Toll-like receptor signaling pathway |
1.29 |
4.13e-1 |
94/104 (90.38%) |
CXCL9;CCL5;CXCL10;...
|
| Cell cycle |
1.28 |
4.18e-1 |
110/124 (88.71%) |
CCNB2;CDC20;ANAPC13;...
|
| Serotonergic synapse |
1.28 |
4.06e-1 |
97/114 (85.09%) |
PRKACB;MAOA;ALOX5;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.28 |
4.03e-1 |
97/100 (97%) |
COL4A5;CCL2;CDC42;...
|
| Retinol metabolism |
-1.19 |
6.47e-1 |
41/68 (60.29%) |
CYP2C18;ALDH1A2;RDH11;...
|
| Phosphonate and phosphinate metabolism |
-1.22 |
6.41e-1 |
5/6 (83.33%) |
CEPT1;CHPT1
|
| Cardiac muscle contraction |
-1.23 |
6.21e-1 |
64/87 (73.56%) |
MYL2;SLC9A6;COX6B1;...
|
| Breast cancer |
-1.23 |
6.24e-1 |
119/147 (80.95%) |
JAG2;ESR2;ESR1;...
|
| Wnt signaling pathway |
-1.23 |
6.35e-1 |
124/166 (74.7%) |
CER1;NFATC1;MYC;...
|
| Renin-angiotensin system |
-1.24 |
6.44e-1 |
20/23 (86.96%) |
CTSA;AGTR1;CTSG
|
| Adherens junction |
-1.25 |
6.48e-1 |
63/71 (88.73%) |
ACTN4;PTPRJ;ERBB2;...
|
| Glycerophospholipid metabolism |
-1.28 |
6.45e-1 |
71/98 (72.45%) |
MBOAT7;CDIPT;LPCAT1;...
|
| Pantothenate and CoA biosynthesis |
-1.28 |
6.48e-1 |
14/21 (66.67%) |
BCAT1;PANK3;DPYD;...
|
| Neuroactive ligand-receptor interaction |
-1.30 |
6.07e-1 |
294/341 (86.22%) |
TSHB;PTGER1;CSH1;...
|
| Neutrophil extracellular trap formation |
-1.31 |
6.15e-1 |
101/189 (53.44%) |
PLCG1;FGG;CYBB;...
|
| Steroid biosynthesis |
-1.31 |
6.17e-1 |
19/20 (95%) |
NSDHL;CYP51A1;MSMO1;...
|
| Phospholipase D signaling pathway |
-1.33 |
5.86e-1 |
134/148 (90.54%) |
PLCB2;PDGFRA;DNM1;...
|
| Fatty acid degradation |
-1.34 |
5.59e-1 |
40/43 (93.02%) |
CPT2;ACAA1;ACSL6;...
|
| Ether lipid metabolism |
-1.35 |
5.50e-1 |
32/49 (65.31%) |
PLA2G10;ENPP2;PLA2G2F;...
|
| Melanoma |
-1.35 |
5.59e-1 |
68/72 (94.44%) |
FGF1;BRAF;FGF6;...
|
| Malaria |
-1.36 |
5.68e-1 |
44/50 (88%) |
SDC2;CSF3;CR1;...
|
| Legionellosis |
-1.37 |
5.72e-1 |
51/57 (89.47%) |
TLR5;HSPD1;HSPA1A;...
|
| Glioma |
-1.39 |
5.45e-1 |
67/75 (89.33%) |
BRAF;CDKN1A;KRAS;...
|
| Sulfur metabolism |
-1.40 |
5.40e-1 |
9/10 (90%) |
MPST;PAPSS2
|
| HIF-1 signaling pathway |
-1.42 |
5.09e-1 |
105/109 (96.33%) |
PLCG1;FLT1;HK3;...
|
| Synaptic vesicle cycle |
-1.45 |
4.45e-1 |
63/78 (80.77%) |
CLTB;ATP6V1B2;SLC6A13;...
|
| Glycerolipid metabolism |
-1.47 |
4.25e-1 |
44/61 (72.13%) |
PLPP3;LPL;ALDH3A2;...
|
| Arginine biosynthesis |
-1.47 |
4.54e-1 |
17/22 (77.27%) |
GOT1;ASS1;GLUL;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.48 |
4.60e-1 |
62/70 (88.57%) |
PLCG1;NOD1;CSK;...
|
| Lysosome |
-1.50 |
4.63e-1 |
115/128 (89.84%) |
CTSE;CD63;PLA2G15;...
|
| Regulation of lipolysis in adipocytes |
-1.51 |
4.97e-1 |
52/55 (94.55%) |
PTGS2;NPR1;ADCY2;...
|
| Phagosome |
-1.52 |
5.59e-1 |
118/152 (77.63%) |
MARCO;ACTB;HLA-DRB1;...
|
| Taurine and hypotaurine metabolism |
-1.58 |
5.31e-1 |
8/11 (72.73%) |
GGT1;CSAD;GAD1;...
|
| Cholesterol metabolism |
-1.64 |
4.76e-1 |
44/50 (88%) |
TSPO;LIPA;STAR;...
|
